Portfolio company
Akouos
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops gene therapies to restore, improve and preserve hearing for individuals with disabling sensorineural hearing loss.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sensorion
This company develops gene therapies and small molecule drugs to restore, treat and prevent inner ear disorders for patients with hearing loss.
Decibel Therapeutics
This biotechnology company develops gene therapies to restore hearing and balance for patients with congenital hearing loss and related genetic disorders.
CamGene
This company develops RNA-based therapeutics using lipid nanoparticle technology to treat hearing loss for patients with cellular dysfunction or undergoing cochlear implant surgery.
CamGene Therapeutics
This biotechnology company develops RNA-based medicines and lipid nanoparticle delivery technologies to treat hearing loss for patients with cellular dysfunction or cochlear implants.
Coave Therapeutics
The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.
Sonothera Therapeutics
This company develops a non-viral gene therapy platform using ultrasound and microbubbles to deliver genetic medicines for patients with serious diseases.
Audentes Therapeutics
The company develops gene therapy products to treat patients with serious and rare neuromuscular diseases.
Atsena
This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.
